94 related articles for article (PubMed ID: 24075957)
1. Static magnetic fields increase tumor microvessel leakiness and improve antitumoral efficacy in combination with paclitaxel.
Gellrich D; Becker S; Strieth S
Cancer Lett; 2014 Feb; 343(1):107-14. PubMed ID: 24075957
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin.
Strieth S; Eichhorn ME; Werner A; Sauer B; Teifel M; Michaelis U; Berghaus A; Dellian M
Clin Cancer Res; 2008 Jul; 14(14):4603-11. PubMed ID: 18628475
[TBL] [Abstract][Full Text] [Related]
3. Static magnetic fields impair angiogenesis and growth of solid tumors in vivo.
Strelczyk D; Eichhorn ME; Luedemann S; Brix G; Dellian M; Berghaus A; Strieth S
Cancer Biol Ther; 2009 Sep; 8(18):1756-62. PubMed ID: 19633422
[TBL] [Abstract][Full Text] [Related]
4. Static magnetic fields induce blood flow decrease and platelet adherence in tumor microvessels.
Strieth S; Strelczyk D; Eichhorn ME; Dellian M; Luedemann S; Griebel J; Bellemann M; Berghaus A; Brix G
Cancer Biol Ther; 2008 Jun; 7(6):814-9. PubMed ID: 18340115
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Exposure to Static Magnetic Field Affects Targeted Therapy of Solid Tumors
Gellrich D; Schmidtmayer U; Eckrich J; Hagemann J; Becker S; Strieth S
Anticancer Res; 2018 Aug; 38(8):4549-4555. PubMed ID: 30061221
[TBL] [Abstract][Full Text] [Related]
6. Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes.
Strieth S; Nussbaum CF; Eichhorn ME; Fuhrmann M; Teifel M; Michaelis U; Berghaus A; Dellian M
Int J Cancer; 2008 Jan; 122(2):452-60. PubMed ID: 17918179
[TBL] [Abstract][Full Text] [Related]
7. Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.
Strieth S; Eichhorn ME; Sauer B; Schulze B; Teifel M; Michaelis U; Dellian M
Int J Cancer; 2004 May; 110(1):117-24. PubMed ID: 15054876
[TBL] [Abstract][Full Text] [Related]
8. Biologic effects of SMF and paclitaxel on K562 human leukemia cells.
Sun RG; Chen WF; Qi H; Zhang K; Bu T; Liu Y; Wang SR
Gen Physiol Biophys; 2012 Mar; 31(1):1-10. PubMed ID: 22447825
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.
Dirkx AE; oude Egbrink MG; Castermans K; van der Schaft DW; Thijssen VL; Dings RP; Kwee L; Mayo KH; Wagstaff J; Bouma-ter Steege JC; Griffioen AW
FASEB J; 2006 Apr; 20(6):621-30. PubMed ID: 16581970
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-dose Paclitaxel and docetaxel on endothelial progenitor cells.
Muta M; Yanagawa T; Sai Y; Saji S; Suzuki E; Aruga T; Kuroi K; Matsumoto G; Toi M; Nakashima E
Oncology; 2009; 77(3-4):182-91. PubMed ID: 19729975
[TBL] [Abstract][Full Text] [Related]
11. Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.
Schmitt-Sody M; Strieth S; Krasnici S; Sauer B; Schulze B; Teifel M; Michaelis U; Naujoks K; Dellian M
Clin Cancer Res; 2003 Jun; 9(6):2335-41. PubMed ID: 12796403
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
Yazici S; Kim SJ; Busby JE; He J; Thaker P; Yokoi K; Fan D; Fidler IJ
Prostate; 2005 Nov; 65(3):203-15. PubMed ID: 15948138
[TBL] [Abstract][Full Text] [Related]
13. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
Inoue K; Slaton JW; Perrotte P; Davis DW; Bruns CJ; Hicklin DJ; McConkey DJ; Sweeney P; Radinsky R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4874-84. PubMed ID: 11156247
[TBL] [Abstract][Full Text] [Related]
15. An investigation into the combined effect of static magnetic fields and different anticancer drugs on K562 cell membranes.
Liu Y; Qi H; Sun RG; Chen WF
Tumori; 2011; 97(3):386-92. PubMed ID: 21789021
[TBL] [Abstract][Full Text] [Related]
16. Effects of a moderate-intensity static magnetic field on VEGF-A stimulated endothelial capillary tubule formation in vitro.
Okano H; Onmori R; Tomita N; Ikada Y
Bioelectromagnetics; 2006 Dec; 27(8):628-40. PubMed ID: 16838273
[TBL] [Abstract][Full Text] [Related]
17. Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol.
Luo Y; Ji X; Liu J; Li Z; Wang W; Chen W; Wang J; Liu Q; Zhang X
Bioelectrochemistry; 2016 Jun; 109():31-40. PubMed ID: 26775206
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells.
Pasquier E; Honore S; Pourroy B; Jordan MA; Lehmann M; Briand C; Braguer D
Cancer Res; 2005 Mar; 65(6):2433-40. PubMed ID: 15781659
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.
Dickson PV; Hamner JB; Sims TL; Fraga CH; Ng CY; Rajasekeran S; Hagedorn NL; McCarville MB; Stewart CF; Davidoff AM
Clin Cancer Res; 2007 Jul; 13(13):3942-50. PubMed ID: 17606728
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
